Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres

Neuroscience

Volumn 81, Issue 1, 1997, Pages 255-262

  Sorkin, L S ^a   Xiao, W H ^a   Wagner, R ^a   Myers, R R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; Hyperalgesia; Inflammation; Neuropathic pain; Rats; Receptor sensitization

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AFFERENT NERVE GROUP 1; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; MALE; NOCICEPTION; NONHUMAN; PAIN PARAMETERS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SCIATIC NERVE; SENSITIZATION; SURAL NERVE;

ANIMALS; ELECTROPHYSIOLOGY; HYPERALGESIA; MALE; MECHANORECEPTORS; NERVE FIBERS; NEURONS, AFFERENT; NOCICEPTORS; PAIN; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SENSORY THRESHOLDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030770623     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00147-4     Document Type: Article

References (34)

1. Asbury A. K., Fields H. L. Pain due to peripheral nerve damage: an hypothesis. Neurology. 34:1984;1587-1590.
2. Baldwin R. L., Chang M. P., Bramhill J., Graves S., Bonavida B., Wisnieski B. J. Capacity of tumor necrosis factor to bind and penetrate membranes is pH dependent. J. Immunol. 141:1988;2352-2357.
3. Baldwin R. L., Stolowitz M. L., Hood L., Wisnieski B. J. Structural changes of tumor necrosis factor α associated with membrane insertion and channel formation. Proc. natn. Acad. Sci. U.S.A. 93:1996;1021-1026.
4. Bianchi M., Sacerdote P., Ricciardi-Castagnoli P., Mantegazza P., Panerai A. E. Central effects of tumor necrosis factor α and interleukin-1α on nociceptive thresholds and spontaneous locomotor activity. Neurosci. Lett. 148:1992;76-80.
5. Bove G. M., Light A. R. Unmyelinated nociceptors of rat paraspinal tissues. J. Neurophysiol. 73:1995;1752-1762.
6. Cunha F. Q., Poole S., Lorenzetti B., Ferreira S. H. The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmac. 107:1992;660-664.
7. + channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation. J. Neurosci. 13:1993;1976-1992.
8. Dinarello C. A. The interleukin-1 family: 10 years of discovery. Fedn Am. Socs exp. Biol. J. 8:1994;1314-1325.
9. Elliot M. J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H., Woody J. N. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet. 344:1994;1105-1110.
10. Exley A. R., Smith N., Winer J. B. Tumour necrosis factor-alpha and other cytokines in Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiat. 57:1994;1118-1120.
11. Ferreira S. H., Lorenzetti B. B., Cunha F. Q., Poole S. Bradykinin release of TNF-alpha plays a key role in the development of inflammatory hyperalgesia. Agents Actions. 38:1993;C7-C9.
12. Fukuoka H., Kawatani M., Hisamitsu T., Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin 1-beta in the rat. Brain Res. 657:1994;133-140.
13. Griffin J. W., George R., Ho T. Macrophage systems in peripheral nerves. A review. J. Neuropath. exp. Neurol. 52:1993;553-560.
14. Handwerker H. O., Forster C., Kirchhoff C. Discharge patterns of human C-fibers induced by itching and burning stimuli. J. Neurophysiol. 66:1991;307-315.
15. Heppelmann B., Messlinger K., Neiss W. F., Schmidt R. F. Fine sensory innervation of the knee joint capsule by group II and group IV nerve fibers in the cat. J. comp. Neurol. 351:1995;415-428.
16. Hua X.-Y., Chen P., Fox A., Myers R. R. Involvement of cytokines in lipopolysaccaride-induced facilitation of CGRP release from capsaicin sensitive nerves in the trachea: studies with IL-1β and TNF-α J. Neurosci. 16:1996;4742-4748.
17. Kagan B. L., Baldwin R. L., Munoz D., Wisnieski B. J. Formation of ion-permeable channels by tumor necrosis factor-α Science. 255:1992;1427-1430.
18. Mendell L. M. Physiologic properties of unmyelinated fiber projections to the spinal cord. Expl Neurol. 16:1966;316-332.
19. Myers R. R., Heckman H. M., Rodriguez M. Reduced hyperalgesia in nerve-injured WLD mice: relationship to nerve fiber phagocytosis, axonal degeneration and regeneration in normal mice. Expl Neurol. 141:1996;94-101.
20. Pafford C. M., Lopshire J. C., Nicol G. D. Tumor necrosis factor (TNFα), but not interleukin 1-β (IL-1-β), enhances the capsaicin sensitivity of rat sensory neurons. Soc. Neurosci. Abstr. 22:1996;1811.
21. Perkins M. N., Kelly D. Interleukin-1 beta-induced desArg9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology. 33:1994;657-660.
22. Puig S., Sorkin L. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase 2 activity. Pain. 64:1996;345-355.
23. Reeh P., Bayer J., Kocher L., Handwerker H. Sensitization of nociceptive cutaneous nerves from the rat's tail by noxious mechanical stimulation. Expl Brain Res. 65:1987;505-512.
24. Said G., Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599.
25. Shafer D. M., Assael L., White L. B., Rossomando E. F. Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J. Oral Maxillofacial Surg. 52:1994;786-791.
26. Thomas P. K. (1979) Painful neuropathies. In Advances in Pain Research and Therapy (ed. Bonica J. J.), Vol. 3, pp. 103-110. Raven, New York.
27. Tracey K. J., Lowry S. F., Beutler B., Cerami A., Albert J. D., Shires G. T. Cachectin/tumor necrosis factor mediates changes in skeletal muscle plasma membrane potential. J. exp. Med. 164:1986;1368-1373.
28. Tyor W. R., Wesselingh S. L., Griffin J. W., McArthur J. C., Griffin D. E. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy and sensory neuropathy. J. Acq. Imm. Defic. Synds Human Retrovir. 9:1995;379-388.
29. Wagner R., Myers R. R. Endoneurial injection of TNF-α produces neuropathic pain. NeuroReport. 7:1996;2897-2901.
30. Wagner R., Myers R. R. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience. 73:1996;625-629.
31. Watkins L. R., Goehler L. E., Relton J., Brewer M. T., Maier S. F. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res. 692:1995;244-250.
32. Watkins L. R., Maier S. F., Groehler L. E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 63:1995;289-302.
33. Watkins L. R., Wiertelak E. P., Goehler L. E., Smith K. P., Martin D., Maier S. F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
34. Xiao W.-H., Bennett G. J. Synthetic omega-conopeptides applies to the site of nerve injury suppresses neuropathic pain in rats. J. Pharmac. exp. Ther. 274:1995;666-672.